A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
BioNTech SE
BioNTech SE
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital, Clermont-Ferrand
TaiRx, Inc.
TaiRx, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
Astellas Pharma Inc
Actuate Therapeutics Inc.
Boston Scientific Corporation
Coherus Oncology, Inc.
Centre Oscar Lambret
AbbVie
Psyence Australia Pty Ltd
University of California, San Diego
Sun Yat-sen University
OHSU Knight Cancer Institute
HealthPartners Institute
Centre Leon Berard
Brigham and Women's Hospital
Aalborg University Hospital
Fudan University
TaiRx, Inc.
UNICANCER
Bayer
Leap Therapeutics, Inc.
Institut Bergonié
Blokhin's Russian Cancer Research Center
BioMed Valley Discoveries, Inc
Jazz Pharmaceuticals
NuCana plc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AbbVie
University of California, San Diego
Azienda USL Reggio Emilia - IRCCS
Peking University People's Hospital
PhytoHealth Corporation
Pfizer
Blokhin's Russian Cancer Research Center
Suzhou Teligene Ltd.
Thomas Jefferson University
Janssen Research & Development, LLC
BPGbio
Lukas Biomedical Inc.
UNICANCER
Trishula Therapeutics, Inc.
University of California, San Diego
Al-Azhar University
AstraZeneca
Servier